ORIC Pharmaceuticals, Inc. (ORIC) DCF Valuation

ORIC Pharmaceuticals, Inc. (ORIC) DCF Valuation
  • ✓ Fully Editable: Tailor To Your Needs In Excel Or Sheets
  • ✓ Professional Design: Trusted, Industry-Standard Templates
  • ✓ Pre-Built For Quick And Efficient Use
  • ✓ No Expertise Is Needed; Easy To Follow

ORIC Pharmaceuticals, Inc. (ORIC) Bundle

DCF model
Get Full Bundle:
$25 $15
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7

TOTAL:

Gain insight into your ORIC Pharmaceuticals, Inc. (ORIC) valuation analysis using our sophisticated DCF Calculator! This Excel template comes preloaded with real ORIC data, enabling you to adjust forecasts and assumptions to accurately determine the intrinsic value of ORIC Pharmaceuticals, Inc. (ORIC).


Discounted Cash Flow (DCF) - (USD MM)

Year AY1
2019		 AY2
2020		 AY3
2021		 AY4
2022		 AY5
2023		 FY1
2024		 FY2
2025		 FY3
2026		 FY4
2027		 FY5
2028
Revenue .0 .0 .0 .0 .0 .0 .0 .0 .0 .0
Revenue Growth, % 0 0 0 0 0 0 0 0 0 0
EBITDA -27.5 -74.2 -78.0 -91.8 -109.7 .0 .0 .0 .0 .0
EBITDA, % 100 100 100 100 100 100 100 100 100 100
Depreciation 1.0 1.0 .9 1.0 1.0 .0 .0 .0 .0 .0
Depreciation, % 100 100 100 100 100 100 100 100 100 100
EBIT -28.5 -75.2 -78.9 -92.7 -110.8 .0 .0 .0 .0 .0
EBIT, % 100 100 100 100 100 100 100 100 100 100
Total Cash 89.2 293.6 237.0 206.3 208.2 .0 .0 .0 .0 .0
Total Cash, percent .0 .0 .0 .0 .0 .0 .0 .0 .0 .0
Account Receivables .0 .0 .0 .0 .0
Account Receivables, % 100 100 100 100 100
Inventories .0 .0 .0 .0 .0 .0 .0 .0 .0 .0
Inventories, % 100 100 100 100 100 100 100 100 100 100
Accounts Payable .2 .8 1.9 1.3 .9 .0 .0 .0 .0 .0
Accounts Payable, % 100 100 100 100 100 100 100 100 100 100
Capital Expenditure -.8 -.7 -.9 -2.1 -.8 .0 .0 .0 .0 .0
Capital Expenditure, % 100 100 100 100 100 0 0 0 0 0
Tax Rate, % 0 0 0 0 0 0 0 0 0 0
EBITAT -27.1 -99.2 -77.8 -95.2 -110.8 .0 .0 .0 .0 .0
Depreciation
Changes in Account Receivables
Changes in Inventories
Changes in Accounts Payable
Capital Expenditure
UFCF -26.7 -98.3 -76.7 -96.9 -111.0 -.9 .0 .0 .0 .0
WACC, % 9.62 9.62 9.62 9.62 9.62 9.62 9.62 9.62 9.62 9.62
PV UFCF
SUM PV UFCF -.9
Long Term Growth Rate, % 2.00
Free cash flow (T + 1) 0
Terminal Value 0
Present Terminal Value 0
Enterprise Value -1
Net Debt -13
Equity Value 12
Diluted Shares Outstanding, MM 51
Equity Value Per Share 0.24

What You Will Get

  • Real ORIC Financial Data: Pre-filled with ORIC Pharmaceuticals’ historical and projected data for precise analysis.
  • Fully Editable Template: Modify key inputs like revenue growth, WACC, and EBITDA % with ease.
  • Automatic Calculations: See ORIC’s intrinsic value update instantly based on your changes.
  • Professional Valuation Tool: Designed for investors, analysts, and consultants seeking accurate DCF results.
  • User-Friendly Design: Simple structure and clear instructions for all experience levels.

Key Features

  • Customizable Clinical Parameters: Adjust key inputs such as trial phases, patient enrollment rates, and treatment efficacy.
  • Instant Valuation Metrics: Quickly computes intrinsic value, NPV, and other financial indicators.
  • High-Precision Analytics: Leverages ORIC Pharmaceuticals’ actual financial data for accurate valuation results.
  • Streamlined Scenario Testing: Easily evaluate various assumptions and assess different outcomes.
  • Efficiency Booster: Remove the complexity of creating intricate valuation models from the ground up.

How It Works

  • 1. Download the Template: Obtain and open the Excel file containing ORIC Pharmaceuticals, Inc. (ORIC) preloaded data.
  • 2. Modify Assumptions: Adjust critical inputs such as growth projections, WACC, and capital expenditures.
  • 3. Analyze Results Instantly: The DCF model automatically computes intrinsic value and NPV.
  • 4. Explore Scenarios: Evaluate various forecasts to investigate different valuation possibilities.
  • 5. Present with Assurance: Deliver professional valuation insights to reinforce your strategic decisions.

Why Choose This Calculator for ORIC Pharmaceuticals, Inc. (ORIC)?

  • Designed for Experts: A sophisticated tool utilized by researchers, financial analysts, and investors.
  • Comprehensive Data: ORIC's historical and projected financials are preloaded for precise analysis.
  • Flexible Scenario Analysis: Effortlessly simulate various forecasts and assumptions.
  • Insightful Results: Automatically computes intrinsic value, NPV, and essential metrics.
  • User-Friendly: Detailed step-by-step instructions make navigation simple.

Who Should Use This Product?

  • Professional Investors: Develop comprehensive and accurate valuation models for portfolio assessment related to ORIC Pharmaceuticals, Inc. (ORIC).
  • Corporate Finance Teams: Evaluate valuation scenarios to inform strategic decisions within their organizations regarding ORIC.
  • Consultants and Advisors: Deliver clients precise valuation insights for ORIC Pharmaceuticals, Inc. (ORIC) stock.
  • Students and Educators: Utilize real-world data to enhance learning and practice in financial modeling with a focus on ORIC.
  • Biotech Enthusiasts: Gain insights into how biotechnology companies like ORIC Pharmaceuticals, Inc. (ORIC) are valued in the market.

What the Template Contains

  • Pre-Filled Data: Includes ORIC Pharmaceuticals' historical financials and forecasts.
  • Discounted Cash Flow Model: Editable DCF valuation model with automatic calculations.
  • Weighted Average Cost of Capital (WACC): A dedicated sheet for calculating WACC based on custom inputs.
  • Key Financial Ratios: Analyze ORIC Pharmaceuticals' profitability, efficiency, and leverage.
  • Customizable Inputs: Edit revenue growth, margins, and tax rates with ease.
  • Clear Dashboard: Charts and tables summarizing key valuation results.

No products were found matching.